Purchase Order 75N95022P00239
- Not listed
- This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. federal government. The $95,173.74 firm-fixed-price purchase order does not have a set-aside designation. IDT has provided a diverse array of products and services through its federal contract awards, including custom DNA oligonucleotides, antisense oligonucleotides for...
- This is a $23,851.14 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Integrated DNA Technologies, Inc. (IDT) for the custom synthesis of 56 antisense oligonucleotides (ASOs) for an in-vivo liver toxicology study. The award has an ultimate completion date of September 30, 2024. IDT is a leading provider of specialized nucleic acid products and services to...
- This is a $14,996.96 firm-fixed-price contract awarded to Integrated DNA Technologies, Inc. (IDT) by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID). The contract is for the provision of custom oligonucleotide and RNA synthesis services. This is a call against a $100 million Blanket Purchase Agreement (BPA) between IDT and the NIH Office of Logistics and Acquisition Operations, which covers the delivery of various biological,...
- This is a firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. federal government. The $5,040 contract is for the delivery of various nucleic acid-based products and services, including custom DNA and RNA oligonucleotides, gene fragments, next-generation sequencing products, primers, probes, and other reagents for...
- This firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Integrated DNA Technologies, Inc. for $701,584. The contract calls for the synthesis of 13,492 antisense oligonucleotides in support of an ongoing SARS-CoV-2 study for the NIH National Institute on Drug Abuse. As the incumbent contractor, Integrated DNA Technologies previously synthesized the oligonucleotides...
- This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH), to Integrated DNA Technologies, Inc. (IDT) for the supply of twelve (12) antisense oligonucleotides (ASOs) for an in-vivo neurotoxicity study. The contract has a ceiling value of $11,940.00 and a period of performance through March 26, 2026. This purchase order does not have a set-aside designation. IDT is a leading...
- This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services. The $20,000 firm-fixed-price contract is for the provision of custom oligonucleotide and RNA synthesis services to support NIAID's research and public health initiatives. This is a Blanket Purchase Agreement (BPA) call order under...
- This contract was awarded to Integrated DNA Technologies, Inc. (IDT), a leading manufacturer and supplier of specialized nucleic acid products and services to the U.S. federal government. The contract is a Blanket Purchase Agreement (BPA) call with a ceiling value of $14,853.75 and a completion date of September 8, 2014. The funding agency is the Office of the Chief Operating Officer, a civilian agency. IDT has provided custom oligonucleotides, antisense oligonucleotides, DNA library kits, exome...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a Firm Fixed Price purchase order to Integrated DNA Technologies, Inc. (IDT) for the custom synthesis of 9 antisense oligonucleotides (ASOs) in support of a liver toxicity study. The order has a potential value of $24,912.77 and a completion date of August 24, 2023. IDT is a manufacturer of nucleic acid products that has previously provided a range of goods and...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Integrated DNA Technologies, Inc. (IDT) for the provision of biological reagents. The contract has a ceiling value of $26,621.50 and a performance period ending on August 31, 2025. IDT is a leading provider of specialized nucleic acid products and services to the federal government, including custom...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Integrated DNA Technologies, Inc. (IDT), a manufacturer of nucleic acid products, for the custom synthesis of 1,536 antisense oligonucleotides in support of the SARS-CoV2 project. The potential value of this contract is $102,912.00. IDT has previously received awards from federal agencies such as the NIH, Centers for Disease Control and Prevention, Department of Defense, and Department of Commerce, both as a prime and subcontractor, to provide a range of goods and services including custom DNA/RNA oligonucleotides, gene fragments, and research materials. IDT also holds an active Federal Supply Schedule contract with the Department of Veterans Affairs to provide oligonucleotides, probes, and custom DNA/RNA synthesized products. This contract was not set aside for any specific socioeconomic group.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Custom Synthesis of 1536 Antisense Oligonucleotides (ASOs) for SARS-CoV2 Project | 75N95022Q00188 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 1/1 | 4/7/22, 1:58 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $102.9k | 4/18/22 |